Home/Stocks/Financials

Legal & General Group PLC

LGEN.L·Financials·Market Cap £14.8b
Rank #36 of 100
Data from Excel Model · 100 Stocks Analysed
£2.67
+1.99% YTD
Target: £2.62(-2.0%)
52W: £2.17 - £2.83
Ad Space

Advertise with Strategyland

strategyland.uk

Score Analysis

Legal & General Group PLC is ranked #36 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

38/100
Average Score
Liquidity
Weak83/100
Valuation
Excellent21/100
Profitability
Excellent5/100
Solvency
Fair55/100
Asset Efficiency
Fair57/100
Mkt Trading
Good35/100
Technical
Excellent11/100

1. Valuation

Score: 21/100

Is LGEN undervalued compared to its peers and fair value metrics?

3/5
valuation criteria met
FY26e P/E Ratio
10.8xRank 19/100
FY27e P/E Ratio
10.0xRank 21/100
Price-to-Book
8.35xRank 90/100
Price-to-Tangible Book
10.71xRank 59/100
EV/EBITDA
0.6xRank 4/100

Key Valuation Metrics

Current P/E
34.2x
Price-to-Earnings
FY26e P/E
10.8x
Forward estimate
FY27e P/E
10.0x
Forward estimate
P/B Ratio
8.35x
Price-to-Book
P/TBV
10.71x
Price-to-Tangible Book
EV/EBITDA
0.6x
Enterprise Value
FY26e EV/EBITDA
1.3x
Forward estimate
FY27e EV/EBITDA
1.3x
Forward estimate

Analyst Consensus Target

Current Price
£2.67
Consensus Target
£2.62
Potential
-2.0%
Target
Bloomberg Median Target: £2.50

2. Profitability

Score: 5/100

How profitable is LGEN relative to its peers?

2/6
profitability criteria met
TTM Profit Margin
1.0%Rank 9/100
Current ROE
19.6%
Current ROA
N/A
FY26e EPS
0.25Rank 10/100
TTM EPS
0.25
Net Income Growth
N/A
Profit Margin
1.0%
ROE
19.6%
FY27e ROE
93.7%
ROA
N/A

Earnings Per Share

3. Financial Health

Score: 55/100

How strong is LGEN's balance sheet and financial position?

0/4
solvency criteria met
Debt-to-Equity
1078.5%
Interest Coverage
N/A
Debt/EBITDA
Rank 88Rank 88/100
Altman Z-Score
N/A

Key Health Metrics

Quick Ratio
N/A
Below 1.0
Cash Ratio
N/A
Debt/Equity
1079%
FCF Margin
0.7%

Altman Z-Score

N/A
Distress Zone
01.812.995+

4. Asset Efficiency

Score: 57/100

How efficiently does LGEN deploy its assets and intellectual capital?

0/2
asset efficiency criteria met
Intangible/Asset
Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations
N/A
R&D/Sales
Research & development spend relative to revenue — balanced R&D investment signals sustainable growth
N/A

Overall Asset Efficiency Rank

Rank within sector peers#57/100
Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.

4. Dividend

LGEN pays a dividend yield of 8.20%.

Current Yield
8.20%
FY27e Yield
8.39%
FY26e DPS
N/A
FY27e DPS
N/A

5. Technical Analysis

Score: 11/100

What do the technical indicators say about LGEN?

2/4
technical criteria met
CMP vs 52W High
-5.5%Rank 18/100
CMP vs 52W Low
23.1%Rank 55/100
RSI 14 Day
66.1Rank 14/100
MA(50) > MA(200)
Yes (Bullish)Rank 55/100

RSI (14 Day)

66.1
Bullish
0 (Oversold)50100 (Overbought)

Moving Averages

MA 30-Day£2.58
MA 50-Day£2.53
MA 200-Day£2.52
SignalGolden Cross (Bullish)
MACD2.00

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

6. Market Trading

Score: 35/100

How liquid and actively traded is LGEN?

1/4
market trading criteria met
5D Avg Volume
35.4M
3M Avg Volume
28.0MRank 8/100
Volume Trend
26.3%
Beta
N/A
Shares Outstanding
5697611241.0m
Free Float
N/A
Enterprise Value
$22752958.6b

Trading Volume

7. Peer Comparison

How does LGEN compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
LGEN#3683215553511
AV.L#4583217432465
BEZG.L#6083223838261
III.L#67301894452286
SDR.L#7083322421754
HSX.L#7383254541707
LLOY.L#76831125803647
Ad Space

Advertise with Strategyland

strategyland.uk

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.